Scientists from the US to Australia are using new technology in an ambitious, multimillion-dollar drive to develop a vaccine in record time to tackle the 2019 novel coronavirus (2019-nCoV) outbreak in China.
The virus has spread rapidly since emerging late last year, killing more than 800 people in China and infecting more than 37,000. Cases have been reported in two dozen other countries.
Coming up with any vaccine typically takes years, and involves a lengthy process of testing on animals, clinical trials on humans and regulatory approvals.
However, several teams of experts are racing to develop one quicker, backed by an international coalition that aims to combat emerging diseases, and Australian scientists hope theirs could be ready in six months.
“It is a high-pressure situation and there is a lot of weight on us,” said senior researcher Keith Chappell, part of the group from Australia’s University of Queensland.
However, the scientist added that he took “some solace” knowing that several teams around the world were engaged in the same mission.
“The hope is that one of these will be successful and can contain this outbreak,” he said.
However, even a time frame of six months looks agonizingly slow with the virus, believed to have emerged from a market selling wild animals, killing close to 100 people every day in China.
Efforts are being led by the Coalition for Epidemic Preparedness Innovations (CEPI), a body established in 2017 to finance costly biotechnology research in the wake of an Ebola outbreak in West Africa that killed more than 11,000 people.
With a mission to speed up the development of vaccines, CEPI is pouring millions of US dollars into four projects around the world and has put out a call for more proposals.
The projects hope to use new technology to develop vaccines that can be tested in the near future.
CEPI chief executive officer Richard Hatchett said the aim was to start clinical testing in just 16 weeks.
German biopharmaceutical company CureVac and US-based Moderna Therapeutics are developing vaccines based on “messenger RNA” — instructions that tell the body to produce proteins — while Inovio, another American firm, is using DNA-based technology.
DNA and RNA-based vaccines use the genetic coding of the virus to trick the body’s cells into producing proteins identical to those on the surface of the pathogen, said Ooi Eng Eong, deputy director of the emerging infectious diseases program at the Duke-NUS Medical School in Singapore.
The immune system learns to recognize the proteins so that it is ready to find and attack the virus when it enters the body.
The Australian researchers are using “molecular clamp” technology invented by the university’s scientists that allows them to rapidly develop new vaccines based solely on a virus DNA sequence.
French scientists at the Pasteur Institute are modifying the measles vaccine to work against 2019-nCoV, but do not expect it to be ready for about 20 months.
Meanwhile, the Chinese Center for Disease Control and Prevention has also started developing vaccines, state-run Xinhua news agency has reported.
Health authorities weigh the risks and benefits in vaccine approvals and if there is a public health emergency, the process could be shortened, Ooi said.
Chinese President Xi Jinping (習近平) is to visit Russia next month for a summit of the BRICS bloc of developing economies, Chinese Minister of Foreign Affairs Wang Yi (王毅) said on Thursday, a move that comes as Moscow and Beijing seek to counter the West’s global influence. Xi’s visit to Russia would be his second since the Kremlin sent troops into Ukraine in February 2022. China claims to take a neutral position in the conflict, but it has backed the Kremlin’s contentions that Russia’s action was provoked by the West, and it continues to supply key components needed by Moscow for
Japan scrambled fighter jets after Russian aircraft flew around the archipelago for the first time in five years, Tokyo said yesterday. From Thursday morning to afternoon, the Russian Tu-142 aircraft flew from the sea between Japan and South Korea toward the southern Okinawa region, the Japanese Ministry of Defense said in a statement. They then traveled north over the Pacific Ocean and finished their journey off the northern island of Hokkaido, it added. The planes did not enter Japanese airspace, but flew over an area subject to a territorial dispute between Japan and Russia, a ministry official said. “In response, we mobilized Air Self-Defense
CRITICISM: ‘One has to choose the lesser of two evils,’ Pope Francis said, as he criticized Trump’s anti-immigrant policies and Harris’ pro-choice position Pope Francis on Friday accused both former US president Donald Trump and US Vice President Kamala Harris of being “against life” as he returned to Rome from a 12-day tour of the Asia-Pacific region. The 87-year-old pontiff’s comments on the US presidential hopefuls came as he defied health concerns to connect with believers from the jungle of Papua New Guinea to the skyscrapers of Singapore. It was Francis’ longest trip in duration and distance since becoming head of the world’s nearly 1.4 billion Roman Catholics more than 11 years ago. Despite the marathon visit, he held a long and spirited
China would train thousands of foreign law enforcement officers to see the world order “develop in a more fair, reasonable and efficient direction,” its minister for public security has said. “We will [also] send police consultants to countries in need to conduct training to help them quickly and effectively improve their law enforcement capabilities,” Chinese Minister of Public Security Wang Xiaohong (王小洪) told an annual global security forum. Wang made the announcement in the eastern city of Lianyungang on Monday in front of law enforcement representatives from 122 countries, regions and international organizations such as Interpol. The forum is part of ongoing